Deutsche Bank Aktiengesellschaft Has Lowered Expectations for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target cut by research analysts at Deutsche Bank Aktiengesellschaft from $342.00 to $322.00 in a report released on Thursday,MarketScreener reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 14.36% from the company’s previous close.

Several other research analysts also recently commented on CME. Raymond James Financial raised their price objective on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Jefferies Financial Group reduced their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. TD Cowen reduced their price objective on CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a report on Thursday. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a report on Saturday, April 18th. Finally, Piper Sandler raised their price objective on CME Group from $313.00 to $329.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, CME Group presently has an average rating of “Moderate Buy” and an average target price of $306.71.

CME Group Trading Down 1.4%

Shares of NASDAQ CME traded down $3.89 during midday trading on Thursday, hitting $281.58. The company’s stock had a trading volume of 94,120 shares, compared to its average volume of 2,289,486. The business’s 50 day moving average is $304.87 and its two-hundred day moving average is $285.91. The firm has a market cap of $100.98 billion, a P/E ratio of 24.02, a price-to-earnings-growth ratio of 2.91 and a beta of 0.26. CME Group has a 12-month low of $257.17 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.03 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period last year, the business posted $2.80 EPS. As a group, equities research analysts expect that CME Group will post 12.37 EPS for the current year.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the sale, the director owned 43,007 shares of the company’s stock, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of the stock in a transaction on Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the sale, the director directly owned 24,999 shares in the company, valued at $7,647,194.10. This trade represents a 1.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 8,539 shares of company stock worth $2,713,821 over the last quarter. Insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Caldwell Trust Co boosted its position in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 50 shares in the last quarter. Asset Dedication LLC boosted its position in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of CME Group in the 3rd quarter worth $27,000. FNY Investment Advisers LLC acquired a new stake in shares of CME Group in the 4th quarter worth $27,000. Finally, Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group in the 4th quarter worth $27,000. Institutional investors own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and surge in trading volumes: CME reported record Q1 revenue and a big rise in average daily volume, driven by increased hedging and risk-taking activity—this is the primary driver for the stock’s upside today. Article Title
• Positive Sentiment: Morgan Stanley trims target but stays Overweight: Morgan Stanley cut its PT to $353 from $362 but kept an Overweight rating, signaling continued analyst confidence and upside (~23.7% from the referenced price). Article Title
• Positive Sentiment: TD Cowen lowers target but maintains Buy: TD Cowen trimmed its PT to $323 (from $340) but kept a Buy rating, indicating analysts still see material upside despite more conservative forecasts. Article Title
• Neutral Sentiment: Earnings-call detail and full transcripts available: Management’s call and full transcripts provide color on product mix, client behavior, and seasonality—useful for modeling but not new headline catalysts. Article Title
• Negative Sentiment: Some outlets say Q1 sales/metrics missed estimates: Several reports note revenue or sales came in below analyst expectations on a few metrics despite strong volumes—this fuels profit-taking and keeps upside capped. Article Title
• Negative Sentiment: Goldman cuts target to $267 and retains Sell: Goldman Sachs lowered its PT and continues to carry a Sell rating, which adds downward pressure and contributes to mixed analyst chatter. Article Title
• Negative Sentiment: Some analysts warn valuation remains high: Commentary (e.g., Seeking Alpha) points out the stock still looks expensive on forward multiples despite strong top-line momentum—this may limit sustained upside. Article Title

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.